U.S. Colorectal Cancer Screening Market is Segmented By Test Type (Fecal Immunochemical Test (FIT), Guaiac-based Fecal Occult Blood Test, Stool DNA Test, and Others), By Imaging Type (Sigmoidoscopy, Colonoscopy, Virtual Colonoscopy, and Others), By End User (Hospitals, Diagnostic Laboratories, Academic and Research Institutes, and Others). The report offers the value (in USD billion) for the above-mentioned segments.
I principali giocatori che operano nel mercato dello screening del cancro del colon-retto degli Stati Uniti includono Polymedco Inc., Eiken Chemical Co. Ltd., Sysmex Corporation, Quidel Corporation, Novigenix SA, Hemosure Inc., Exact Sciences Corp., Epigenomics Inc. Corporation, Clinical Genomics Technologies Pty Ltd., Abbott, F. Hoffmann-La Roche Ltd.
U.S. Colorectal Cancer Screening Market